Trial ID or NCT#

NCT00767234

Status

not recruiting iconNOT RECRUITING

Purpose

To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of individuals who will go on to develop a clotting complication.

Official Title

Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Philip S. Tsao, PhD
Lawrence "Rusty" Hofmann, MD
Lawrence "Rusty" Hofmann, MD
Interventional radiologist
Professor of Radiology (Interventional Radiology)
Thomas Quertermous, MD
Jeffrey Norton, MD
Jeffrey Norton, MD
Surgical oncologist
Robert L. and Mary Ellenburg Professor of Surgery
George A. Fisher Jr.
George A. Fisher Jr.
Medical oncologist, Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine

Contact us to find out if this trial is right for you.

CONTACT

CCTO
(650) 498-7061